ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Post-marketing safety evaluation and objective benefit-risk assessment of sublingual immunotherapy tablets in allergic rhinitis.

Eleonora Castellana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.